Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rivaroxaban for left atrial/left atrial appendage thrombus in nonvalvular atrial fibrillation or atrial flutter
2012-001062-15Phase 3Completed
- Sponsor
- Bayer
- Start
- Mar 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rivaroxaban in Atrial fibrillation (AFib), atrial flutter (AFL), sponsored by Bayer. Started Mar 2013; status: completed.
02
Drugs
rivaroxaban
03
Conditions
Atrial fibrillation (AFib)atrial flutter (AFL)
Beyond the preview
Go deeper on 2012-001062-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001062-15.